Neurocrine(IT:1NBIX)
€148.90-2.90 (-1.91%)
IT:1NBIX
Neurocrine earnings date
€148.90
At close:-2.90 (-1.91%)
Neurocrine (1NBIX) Q2 2026 Earnings Report
0 Followers
IT:1NBIX Q2 2026 EPS Results
- Actual EPS
- EUR 1.26
- Consensus EPS
- EUR 1.50
- Beat/Miss
- Missed by -EUR 0.23
- One Year Ago EPS
- EUR 0.96
IT:1NBIX Q2 2026 Revenue Results
- Actual Revenue
- EUR 870.05M
- Expected Revenue
- EUR 808.50M
- Beat/Miss
- Beat by +EUR 61.55M
- YoY Revenue Growth
- +39.49%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/30/2026
- Time
- After Close
- Conference Call
- Thursday, July 30, 2026
IT:1NBIX Upcoming Earnings
Neurocrine's next earnings date is estimated for February 11, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
IT:1NBIX Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
IT:1NBIX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 11, 2027 | 2026 (Q4) | 1.88- | 1.34 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 1.731.78 | 1.85 | -3.92% (-0.07) | |
| Jul 30, 2026 | 2026 (Q2) | 1.501.26 | 0.96 | 31.13% (+0.30) | |
| May 05, 2026 | 2026 (Q1) | 1.101.73 | 0.07 | 2287.50% (+1.66) | |
| Feb 11, 2026 | 2025 (Q4) | 1.641.34 | 0.91 | 48.00% (+0.44) | |
| Oct 28, 2025 | 2025 (Q3) | 1.451.85 | 1.12 | 64.52% (+0.73) | |
| Jul 30, 2025 | 2025 (Q2) | 0.880.96 | 0.57 | 68.25% (+0.39) | |
| May 05, 2025 | 2025 (Q1) | 0.490.07 | 0.38 | -80.95% (-0.31) | |
| Feb 06, 2025 | 2024 (Q4) | 1.460.91 | 1.31 | -30.56% (-0.40) | |
| Oct 30, 2024 | 2024 (Q3) | 1.351.12 | 0.74 | 51.22% (+0.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


